Prostate DB is a therapeutic drug for symptoms related to benign prostatic hyperplasia.

1、 Drug name

1. Common name: Prostate DB (Evirostat) combined with tablets

2. English name: EvirostatTablets

2、 Indications

Used to treat symptoms such as difficulty urinating, residual urine sensation, residual urine, and frequent urination associated with prostate enlargement.

3、 Specifications and characteristics

1. This product is a white, enteric coated film tablet.

2. Each tablet contains active ingredient extracts and various excipients, and its appearance is designed for easy swallowing and intestinal dissolution and absorption.

4、 Main components

Each tablet contains the following active ingredients:

1. Ursa leaf extract: 1mg

2. Ha Kou Ya Na ギキス (Yang bark extract): 1mg

3. White Headed Weng Extract: 1mg

4. Snakes (Wood Thief Extract): 3mg

5. Refined wheat germ oil: 30mg

5、 Usage and dosage

1. Adult standard dosage: 1 tablet each time, 3 times a day, orally.

2. The dosage can be adjusted appropriately according to the severity of symptoms.

6、 Dose adjustment

The specific requirements for adjusting dosage based on age, weight, or kidney function are not clearly listed. It is recommended to make personalized adjustments based on clinical symptoms under the guidance of a doctor.

7、 Medication precautions

1. Usage: The tablets should be taken after being removed from the PTP packaging to avoid ingestion of hard packaging materials that may cause damage to the esophagus.

2. Medication time: Take according to the doctor's prescription at the designated time.

3. Omission treatment: If you forget to take it, you should take it as soon as possible; If it is close to the next medication time, the missed dose should be skipped to avoid double taking.

4. Vomiting situation: If vomiting occurs after taking medication, it is recommended not to take it again and wait until the next normal medication is taken.

8、 Medication for special populations

1. Elderly people: It can be reduced or used cautiously according to symptoms.

2. Children: Not specified for specific target audience, usually not used for children.

3. Pregnant or lactating women: Safety data is not clearly stated in the data, it is recommended to use with caution or under the guidance of a doctor.

9、 Adverse reactions

According to clinical investigations and equivalence trials, the following adverse reactions may occur:

1. Digestive system: loss of appetite, abdominal pain, stomach discomfort, nausea, stomach pain (incidence rate 0.1-5%).

2. Skin: rash, itching, erythema multiforme (incidence unknown).

3. Liver: Abnormal liver function, jaundice.

4. Metabolic abnormalities: Elevated uric acid in the blood.

5. Other: feelings of fatigue and numbness.

6. When serious adverse reactions occur, the medication should be discontinued and medical attention sought.

10、 Contraindications

Individuals allergic to any ingredient of this product are prohibited from using it.

11、 Drug interactions

It is recommended to use other medications in combination, especially anti-inflammatory drugs, diuretics, etc., under the guidance of a doctor.

12、 Storage method

1. It should be stored in a cool and dry place, avoiding high temperature and humidity.

2. Keep out of reach of children.

13、 Manufacturer

1. Manufacturing and sales party: Nippon Shin chan Co., Ltd.

2. Address: 14 Nishi no Shomon cho, Jichiwon, Minami ku, Kyoto City.

Eviprostatinformation